GoodRx Holdings, Inc.
GDRX
$3.91
-$0.3609-8.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 202.97M | 198.58M | 195.25M | 200.61M | 197.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 202.97M | 198.58M | 195.25M | 200.61M | 197.88M |
| Cost of Revenue | 13.36M | 12.19M | 11.68M | 11.87M | 12.47M |
| Gross Profit | 189.61M | 186.39M | 183.57M | 188.74M | 185.41M |
| SG&A Expenses | 109.76M | 97.02M | 115.49M | 121.04M | 118.07M |
| Depreciation & Amortization | 20.91M | 19.10M | 17.54M | 16.97M | 15.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 175.18M | 160.05M | 174.84M | 180.73M | 177.50M |
| Operating Income | 27.79M | 38.54M | 20.41M | 19.88M | 20.38M |
| Income Before Tax | 16.67M | 11.41M | 8.11M | 11.65M | 293.00K |
| Income Tax Expenses | 5.62M | 4.67M | 4.15M | 4.95M | 1.30M |
| Earnings from Continuing Operations | 11.05M | 6.74M | 3.97M | 6.69M | -1.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.05M | 6.74M | 3.97M | 6.69M | -1.01M |
| EBIT | 27.79M | 38.54M | 20.41M | 19.88M | 20.38M |
| EBITDA | 48.70M | 41.87M | 37.94M | 36.84M | 36.32M |
| EPS Basic | 0.03 | 0.02 | 0.01 | 0.02 | 0.00 |
| Normalized Basic EPS | 0.03 | 0.05 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.03 | 0.02 | 0.01 | 0.02 | 0.00 |
| Normalized Diluted EPS | 0.03 | 0.05 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 379.20M | 381.61M | 379.67M | 376.25M | 390.05M |
| Average Diluted Shares Outstanding | 379.66M | 383.58M | 388.50M | 384.73M | 390.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |